Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial

被引：0
作者：
Lisa M. Pitchford
Patricia M. Driver
John C. Fuller
Wendell S. Akers
Naji N. Abumrad
Venkataraman Amarnath
Ginger L. Milne
Sheau-Chiann Chen
Fei Ye
L. Jackson Roberts
M. Benjamin Shoemaker
John A. Oates
John A. Rathmacher
Olivier Boutaud
机构：
[1] MTI BioTech,Department of Kinesiology
[2] Inc.,Department of Medicine, Division of Clinical Pharmacology
[3] Iowa State University,Department of Pharmaceutical Sciences
[4] Vanderbilt University Medical Center,Department of Pharmacology, Division of Clinical Pharmacology
[5] Lipscomb University College of Pharmacy,Department of Surgery
[6] Vanderbilt University,Department of Biostatistics
[7] Vanderbilt University Medical Center,Department of Medicine, Division of Cardiology
[8] Vanderbilt University Medical Center,Department of Animal Science
[9] Vanderbilt University Medical Center,undefined
[10] Iowa State University,undefined
来源：
BMC Pharmacology and Toxicology | / 21卷
关键词：
Safety; Pharmacokinetics; Humans; Salicylamine; γ-Ketoaldehydes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial
    Pitchford, Lisa M.
    Driver, Patricia M.
    Fuller, John C., Jr.
    Akers, Wendell S.
    Abumrad, Naji N.
    Amarnath, Venkataraman
    Milne, Ginger L.
    Chen, Sheau-Chiann
    Ye, Fei
    Roberts, L. Jackson, II
    Shoemaker, M. Benjamin
    Oates, John A.
    Rathmacher, John A.
    Boutaud, Olivier
    BMC PHARMACOLOGY & TOXICOLOGY, 2020, 21 (01)
  • [2] A Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeated Doses of Mirogabalin in Healthy Asian Volunteers
    Jansen, Mendel
    Warrington, Steven
    Dishy, Victor
    Ohwada, Shoichi
    Johnson, Lisa
    Brown, Karen
    Ishizuka, Hitoshi
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (06): : 661 - 669
  • [3] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers
    Fukumura, Kazuya
    Yokota, Takaaki
    Baba, Yuko
    Ferreira, Juan Camilo Arjona
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (05): : 474 - 483
  • [4] Safety and tolerability of Ganoderma lucidum in healthy subjects:: A double-blind randomized placebo-controlled trial
    Wicks, Sheila M.
    Tong, Robin
    Wang, Chong-Zhi
    O'Connor, Michael
    Karrison, Theodore
    Li, Shang
    Moss, Jonathan
    Yuan, Chun-Su
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2007, 35 (03): : 407 - 414
  • [5] Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study
    Li, Yi
    Toyama, Kaoru
    Nakatsu, Takafumi
    Ishizuka, Hitoshi
    Wu, Hailan
    Cao, Guoying
    Yu, Jicheng
    Wang, Yu
    Liu, Xiaofen
    Guo, Beining
    Wu, Jufang
    Yu, Peimin
    Hong, Zhen
    Zhang, Jing
    Wu, Xiaojie
    ADVANCES IN THERAPY, 2023, 40 (04) : 1628 - 1643
  • [6] Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study
    Yi Li
    Kaoru Toyama
    Takafumi Nakatsu
    Hitoshi Ishizuka
    Hailan Wu
    Guoying Cao
    Jicheng Yu
    Yu Wang
    Xiaofen Liu
    Beining Guo
    Jufang Wu
    Peimin Yu
    Zhen Hong
    Jing Zhang
    Xiaojie Wu
    Advances in Therapy, 2023, 40 (4) : 1628 - 1643
  • [7] Safety, tolerance, and pharmacokinetics of salvianolic acid B in healthy Chinese volunteers: A randomized, double-blind, placebo-controlled phase 1 clinical trial
    Cheng, Junlin
    Long, Jun
    Zhang, Jingjing
    Han, Le
    Hu, Yunfang
    Liu, Jianghui
    Qiu, Runze
    Zhu, Zhibin
    Fan, Hongwei
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [8] Safety, tolerability, and pharmacokinetics of ibrexafungerp in healthy Chinese subjects: a randomized, double-blind, placebo-controlled phase 1 trial
    Liu, Xiaoyan
    Zhang, Rui
    Li, Rong
    Wu, Qiong
    Pan, Chao
    Yu, Xiangqing
    Liu, Yuhui
    Wang, Benjie
    Yu, Shuwen
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (12)
  • [9] First-in-human study assessing safety, tolerability, and pharmacokinetics of 2-hydroxybenzylamine acetate, a selective dicarbonyl electrophile scavenger, in healthy volunteers
    Pitchford, Lisa M.
    Rathmacher, John A.
    Fuller, John C., Jr.
    Daniels, J. Scott
    Morrison, Ryan D.
    Akers, Wendall S.
    Abumrad, Naji N.
    Amarnath, Venkataraman
    Currey, Patricia M.
    Roberts, L. Jackson
    Oates, John A.
    Boutaud, Olivier
    BMC PHARMACOLOGY & TOXICOLOGY, 2019, 20 (1)
  • [10] Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study
    Zhao, Qian
    Liu, Hongzhong
    Wang, Zhenlei
    Wang, Teng
    Cui, Cheng
    Wang, Huanhuan
    Li, Lili
    Zhong, Wen
    Jiang, Ji
    Dong, Kai
    Chen, Shuai
    Jin, Chunyan
    Hu, Pei
    ADVANCES IN THERAPY, 2023, 40 (07) : 3186 - 3198
12345